Ultradent Products is a vertically integrated, clinician-founded American manufacturer of dental consumables, materials and small equipment, best known for Opalescence — which the company describes as the world's number one professional teeth-whitening brand — and the VALO family of LED curing lights. Built over 48 years by founder-dentist Dr. Dan Fischer, the company manufactures the overwhelming majority of its 500+ products in South Jordan, Utah, sells directly to U.S. dental practices, and reaches 130+ countries through subsidiaries and distributors. FY2025 consolidated sales were USD 372.1 million with operating income of USD 30.9 million. Its moat rests on brand equity in whitening, an unusually prolific patent culture, direct clinician relationships, and an employee-centric culture recognised by Fortune for five consecutive years. In August 2026 Mitsui Chemicals acquired Ultradent for USD 900 million, making it the U.S. anchor and global headquarters of a combined Ultradent–Kulzer oral-care platform targeting the No. 2 position in global dental materials.
---
**What the company does.** Ultradent researches, designs, manufactures, packages and distributes dental products, materials, devices and application techniques. Its portfolio spans cosmetic dentistry (professional and take-home teeth whitening; whitening toothpaste), restorative dentistry (composites, flowables, adhesives, etchants, temporary resins, finishing and polishing), tissue management (hemostatics, retraction cord), impressions (VPS/PVS materials and dispensing devices), endodontics (files, irrigants, intracanal medicaments, sealers and temporary materials), preventive and hygiene care (fluoride varnishes, prophy handpieces and angles, desensitizers, topical anesthetics), equipment (LED curing lights, soft-tissue diode lasers, protective eyewear), isolation, delivery systems (syringes and tips), and orthodontics (via its Opal Orthodontics brand).
**Company's own description.** Ultradent has no annual report. Its standard corporate description — repeated in every press release — characterises it as a leading developer and manufacturer of high-tech dental materials, devices and instruments worldwide, with a vision to improve oral health globally, and with a parallel commitment to improving quality of life through financial and charitable programs. The acquirer's description (Mitsui notice, 12 Jun 2026) frames Ultradent as a global leader in teeth whitening and dental restorative materials with strong design, development and manufacturing technology and established direct sales channels to dental clinics.
**Independent characterisation.** Ultradent is best understood as a *mid-sized, premium, innovation-led consumables franchise with a razor/razor-blade overlay*. Durable equipment (VALO curing lights, Gemini lasers, Ultrapro Tx handpieces, BFC3 impression gun) creates installed-base relationships in the operatory, while the vast bulk of revenue is believed to come from high-frequency consumables (whitening gels and trays, composites, cord, hemostatics, varnish, tips). Whitening is the profit and brand engine: Opalescence spans in-office (Opalescence Pro), custom-tray take-home (Opalescence Custom), prefilled trays (Opalescence Go, Home Advanced, Go Advanced) and consumer-channel toothpastes, giving Ultradent a dentist-dispensed channel into consumer aesthetics that pure materials companies lack.
**Business model and revenue mix.** Product sales account for effectively all revenue. There is no disclosed subscription or licensing revenue. Service revenue (equipment repair, warranty and "Equipment Services") exists but is not separately disclosed. Continuing education (live and online CE courses, the "Bridges" congress, and a new Leenie Fischer Training Center) functions as a demand-generation tool rather than a revenue line.
**Value chain position.** Ultradent is an integrated manufacturer: in-house R&D, chemistry formulation, injection molding (housed in the 168,000 sq ft building opened in 2023), equipment manufacturing and repair, packaging and distribution. In the U.S. it sells direct to practices (an unusual model in a market dominated by full-line distributors such as Henry Schein, Patterson and Benco), supplemented by distributor and DSO channels. Internationally it uses subsidiaries in Europe, Asia-Pacific and Latin America plus third-party distributors.
**Customer types.** Dentists in private practice; group practices and dental service organisations (DSOs); orthodontists and pediatric dentists; dental and veterinary laboratories; government agencies (dedicated government and formulary programs); universities and dental schools; and, for whitening toothpaste and some take-home products, consumers.
**End-markets served.** Global dental consumables; professional teeth whitening; dental curing lights and soft-tissue lasers; restorative materials; endodontics; preventive dentistry (fluoride), with growing adjacencies in facial esthetics (via the 2026 AAFE/StatDDS partnership).
.svg){kind=icon}
.svg){kind=icon}
.svg){kind=icon}
.svg){kind=icon}
.svg){kind=icon}
.svg){kind=icon}
.svg){kind=icon}
.svg){kind=icon}
.svg){kind=icon}
.svg){kind=icon}
.svg){kind=icon}
.svg){kind=icon}